Andrew T.L. Ong - Concepedia

Author

Andrew T.L. Ong

Also Known As

ANDREW T.L. ONG, Andrew Ong, Andrew T L Ong, Andrew T. L. Ong, Andrew T. Ong, Andrew T.L Ong, Andrew T.L. Ong, Andrew TL Ong, Andrew Tl Ong

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

Erasmus University Rotterdam Erasmus MC Westmead Hospital Tilburg University Cardialysis (Netherlands)

About

Andrew T.L. Ong is an author at Erasmus University Rotterdam specializing in medicine, cardiovascular disease, and percutaneous coronary intervention.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	31	5.8K
2	Public Health	6	6	951
3	Biomedical Engineering	3	3	717
4	Social Sciences	1	1	52
5	Biostatistics	1	1	93

Andrew T.L. Ong

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Eugène McFadden, Eugenio Stabile, Evelyn Regar, The Lancet ThrombosisPercutaneous Coronary InterventionAntiplatelet TherapyCardiovascular DiseaseCoronary Artery Disease	2004	1.4K
Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents Andrew T.L. Ong, Eugène McFadden, Evelyn Regar, Journal of the American College of Cardiology ThrombosisEndovascular TechniqueCardiovascular DiseaseCardiologyPublic Health	2005	661
Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease Patrick W. Serruys, Andrew T.L. Ong, Lex A. van Herwerden, Journal of the American College of Cardiology Percutaneous Coronary InterventionFive-year OutcomesEndovascular TechniqueCardiovascular DiseaseVascular Surgery	2005	614
Endothelial Progenitor Cell Capture by Stents Coated With Antibody Against CD34 Jiro Aoki, Patrick W. Serruys, Heleen van Beusekom, Journal of the American College of Cardiology Cell TherapyVascular DiseaseAngiogenesisImmunologyStents Coated	2005	543
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation Andrew T.L. Ong, Angela Hoye, Jiro Aoki, Journal of the American College of Cardiology ThrombosisEndovascular TechniqueVascular SurgeryThirty-day IncidenceLumen-apposing Metal Stent	2005	431
Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease Marco Valgimigli, Carlos A.G. van Mieghem, Andrew T.L. Ong, Circulation	2005	341
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase Andrew T.L. Ong, Patrick W. Serruys, Frederick W. Mohr, American Heart Journal Percutaneous Coronary InterventionCardiac SurgeryCardiovascular DiseasePatient SafetyOutcomes Research	2006	336
A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. Patrick W. Serruys, Andrew T.L. Ong, Jan J. Piek, PubMed	2005	305
Long-Term Outcomes After Stenting of Bifurcation Lesions With the “Crush” Technique Angela Hoye, Ιoannis Iakovou, Lei Ge, Journal of the American College of Cardiology Vascular SurgeryLumen-apposing Metal StentSurgeryEndovascular ManagementMedicine	2006	240
The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population Andrew T.L. Ong, Patrick W. Serruys, Jiro Aoki, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseasePharmacologyCardiologyUnselected Population	2005	226

Page 1